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ABSTRACT
MER-25, which acts as an antiestrogen on most
estrogen-

sensitive behaviors and in peripheral tissues, acts
only as
an estrogen with respect to eating and body weight.
MER-25
fails to antagonize the effects of EB on eating and body

weight, while simultaneously antagonizing EB's effects on

female sexual behavior, uterine growth, and vaginal cytology.

Estradiol benzoate (EB) and MER-25 similarly affect eating
and body weight in gonadectomized rats and gerbils.

In rats,

both compounds cause a transient decrease in food intake and
a permanent decrease in body weight relative to controls;

the eating and body weight effects of both MER-25 and EB

are attenuated by progesterone; both MER-25 and EB affect

females more than males; MER-25 decreased food intake when

implanted in the same hypothalamic areas in which EB decreases
food intake; and both EB and MER-25 reduce body weight by
means independent of food intake reductions.

In gerbils,

both EB and MER-25 increase food intake and body weight.
The decrease in eating and weight gain caused by MER-25 are

not due to toxicity, as indicated by its failure to induce
a learned aversion to saccharin and its failure to alter

running wheel activity.

These results indicate that the

systems mediating the effects of estrogens on eating and body

weight differ biochemically from other behavioral and somatic

estrogen-sensitive systems.
In studies directed at the inhibitory behavioral actions

of antiestrogens, the hypothesis that
antiestrogens compete
with estradiol for binding sites in the
brain
was tested.

Effects of antiestrogens on estradiol binding
were compared
with their effects on female sexual behavior.
The
non-

steroidal antiestrogens, MER-25, CI628, and nafoxidine
reduce
the uptake of H-estradiol in whole homogenates
and isolated
cell nuclei of brain tissues and in similar paradigms
block
the induction of female sexual behavior.

The antiestrogens

were injected intraperitoneally 2 hours prior to an intra3

venous injection of
2

H-estradiol, and the animals were killed

hours after the estradiol injection.

Cl-628 reduces radio-

activity in whole homogenates and purified cell nuclei of
cerebral cortex, hypothalamus, preoptic area-septum, as well
as the pituitary.

Nafoxidine reduces uptake in cell nuclei

of the hypothalamus, preoptic area-septum, and pituitary.

In this paradigm, MER-25 inhibits uptake in the pituitary,

but not in the brain.

In the analogous behavioral experiments,

with antiestrogens injected

2

hours prior to an intravenous

injection of unesterified estradiol, CI-628 and nafoxidine

totally inhibit lordosis responding.

MER-25 shows no inhi-

bition of behavior in this paradigm.

However, when MER-25

is injected 12 hours prior to the estradiol,

it inhibits

.

3

retention of

H-estradiol at 2 hours in brain and pituitary

cell nuclei, and lordosis responding is also inhibited.

Additionally, the antiestrogens can apparently displace
3

previously bound

H-estradiol.

When the antiestrogens are
3

injected

2

hours prior to an injection of
vi

H-estradiol,

MER-25, CI-628, and nafoxidine all show
greater inhibition
of nuclear estradiol retention at 12
hours after
the

estradiol injection than at

2 hours.

V

Analagously, when CI-

628 is injected 2 hours after an intravenous injection
of

H-estradiol, it displaces most of the radioactivity
present
in hypothalamic-preoptic area nuclei at 12
hours after the

estradiol injection.

These results indicate that anti-

estrogens can prevent or reverse the nuclear concentration
of estradiol in brain cells and are consistent with a role
of the cell nucleus in the induction of estrous behavior by

estradiol.

vii
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INTRODUCTION

Estradiol affects both eating and female
sexual
behavior in rats by actions in the central
nervous system.
Small implants of estradiol in the hypothalamus
cause a
decrease in food intake and induce sexual receptivity

(Beatty et al.,

197i+;

Stem, 197k; Lisk,

Dorner et al., 1968; Jankowiak and

1962; Wade and Zucker, 1970), while

implants in other regions of the brain do not.

Lesions of

parts of the hypothalamus reduce the sensitivity of rats
to the effects of systemic estradiol injections on food

intake (Beatty et al., 1975).

Likewise, lesions of the

diencephalon either enhance or diminish the estrogenresponsiveness of the lordosis reflex, depending on the
location of the damage (Law and Meagher, 1958; Powers and
Valenstein, 1972; Singer, I968).

Antiestrogens may be useful in analyzing the behavioral
actions of estradiol.

These synthetic compounds inhibit

the actions of estrogens on a variety of measures.

The

antiestrogen MER-25 has been studied extensively in a variety
of species and has been found to antagonize the effects of

estrogens on the uterus, vagina, mammary gland, eviduct,
and brain (e.g., Giannina et al.,
1972; Lerner,

I96I4.;

1971+;

Komisaruk and Beyer,

Lerner et al., 1958; McDonald, 1973;

Meyerson and Lindstrom, I968; Sodersten,
Emmens, 1961;; Roy and Wade, 1975).

1971;;

Stone and

For example, estradiol-

induced uterine weight increases can be attenuated
and
vaginal cornif ication prevented by MER-25
administration.

Female sexual behavior and estradiol- induced increases
in
locomotor activity can be inhibited by anties trogens
,

as

well as estradiol-induced alterations in gonadotropin

release (Arai and Gorski, 1968; Labhsetwar, 1970; Roy and
Wade, 1975)-

The compounds do not inhibit or mimic

androgens or progestins (Lerner et al., 1958).

PART

I

EFFECTS OF AN ANTIESTROGEN ON POOD INTAKE

AND BODYWEIGHT
There has been no published study designed to determine

whether anties trogens will inhibit estradiol's actions on
eating and body weight regulation.

In fact, available

data suggest that the antiestrogen MER-25 might itself

produce the same effects as estradiol (Beyer and Vidal,
1971; Lerner et al., 1958; Lerner et al., 1966).

In most mammalian species estradiol decreases eating

and body weight in intact females and ovariectomized
animals given the hormone exogenously.

The effects have

been most clearly characterized in rats (see Wade 1976 for
review):

1)

The effects on food intake of either ovariectomy

(OVX) or continued replacement injections of estradiol

benzoate are transient, while the body weight changes are

permanent (Gentry and Wade, 1976a; Mook et al., 1972;
Tarttelin and Gorski, 1971; Wade, 1975).

2)

Progesterone

antagonizes the action of estradiol on f.i. and BW, but
has no effects of its own (Wade, 1975; Ross and Zucker,
I97I4.).

3) Females are more sensitive than males to the

affect of EB injections on food intake (Gentry and Wade,
1976b),

I|)

Estradiol will produce a reduction of food

intake when implanted in the ventromedial hypothalamus

(Beatty et al.,

197i|;

Zucker, 1970).

5)

Jankowiak and Stem,

1971;;

Wade and

Some actions of EB on body weight reduc-

tion are apparently independent of food
intake change;e3
(Blaustein et al., 1976,
Dubuc, 1976).
;
In female
Mongolian gerbils, estradiol produces effects
on eating and
body weight opposite to those produced in
rats; injections
of EB increase food intake and body weight
(Maass and Wade,

unpublished).
The first experiment assesses the ability of the
anti-

'

estrogen MER-25 to inhibit the effects of EB on food intake
and body weight.

The subsequent studies determine to what

extent the effects on eating and body weight of an antiestrogen, MER-25, parallel those of EB.

General Method
The subjects were Sprague-Dawley rats obtained from

Charles River Breeding Laboratories (Wilmington, Mass.)
and Mongolian gerbils obtained from Tumblebook Farms,
(Northfield, Mass.).

Animals were castrated at various times

before treatment as indicated in each experiment.

Gonad-

ectomies were performed through a single ventral incision

under sodium pentobarbital (Nembutal,
flurane (metofane) anesthesia.

i;0

mg/kg) or methoxy-

Animals were housed indivi-

dually, and the lighting cycle provided 12 hours of light

and dark.

Injections were given daily 1-2 hours prior to

the onset of dark.

Substances to be injected were dissolved

or suspended in sesame oil to a final volume of 0.1 cc

(except the 20 mg dose of MER-25 which was in 0.2 cc oil)
and injected subcutaneously.

Purina Laboratory Chow pellets

were available ad libitum except where otherwise noted.

Pood intake was measured daily in the rat studies
and twice
week in the gerbil study to the nearest 0.1
£
g during
the middle of the light period with spillage collected.

Body weight was measured to the nearest

1

Data were analyzed by the appropriate

test for between-

_t

g every third day.

group or within-group comparisons or by analysis of variance

EXPERIMENT 1.

COMPARISON OF THE EFFECTS OF MER-25

ON THE ACTIONS OF ESTRADIOL ON FOOD INTAKE,
FEMALE

SEXUAL BEHAVIOR, UTERINE WEIGHT, AND VAGINAL CYTOLOGY
This experiment tested whether MER-25 would antagonize

EE's effects on eating and body weight.

Two doses were

tested and concurrent comparisons made with the effects on
sexual behavior, vaginal cytology, and uterine weight.

Procedure
Part 1.

Fourteen females averaging 250 g were ovari-

ectomized; the following day injections were begun.

Group

1

(n=5) received the oil vehicle; Group 2 (n=5) received

2

ug/day of EB; Group

of MER-25.

3

(n=i;

received 2 ug of EB and 5 mg

Pood intake was measured daily and body weight

every third day.

Sexual behavior was tested under red

illumination during the dark phase with male rats on the
i\.th

and 9th days of injection.

Injections were continued

for 22 days, and then the animals were sacrificed and

uterine weights measured.
Part 2.

Thirty females were ovariectomized

prior to treatment.

3l|-

days

Animals were assigned to one of four

groups, balanced according to baseline food intake and

body weight.

The animals received daily injections of oil

(n=8, 2 ug EB (n=8, 20 mg MER-25 (n=7), or 2 ug EB plus
20 mg MER-25 (n=7).

Food intake was measured daily, and

7

body weight was measured on days

3,

6,

and 10 of treatment.

Vaginal. smears were taken daily beginning
on the 3rd day
of treatment. Sexual behavior was
tested during the dark
on days 2, 5, 9, and 10. For testing
on the last day,
500 ug of progesterone was injected
k hours prior to testing.
The response of the female was rated on
a scale
of 0-3

after Powers and Valenstein (1972).

The receptivity score

was the average response to 10 vigorous mounts.

At the

end of treatment all animals were given an overdose
of
sodium pentobarbital and the uterus was removed,
cleaned
of fat and mesentery, blotted and weighed to the
nearest
1 mg.

Naso-anal length was also measured.

Results
Part 1.

Pood intake comparisons were based on indivi-

dual means during the 3rd week when the oil group's food
intake had stabilized above pre-operative levels.

caused a reduction of foo d intake by more than
t(8)=3.68, p<.01. Table 1.
of EE's effect.

i|

EB
g/day,

MER-25 produced no attenuation

The EB plus MER-25 group ate slightly less

than the EB group and 5 g/day less than the oil control,
t{7)=3.70, p<.01.

The effects of the EB and MER-25 on

food intake were not additive at this dose, since the MER-25

group ate the same amount as the EB plus MER-25 group.

Estrogen antagonism was likewise not seen for body weight
effects (Table 1)
additive.

the effects of EB and MER-25 were

The EB plus MER-25 group gained less than the

MER-25 group,

t(7)=2.l4.8,

p<.05.

MER-25 caused a significant

,

Table 1.

Effects of estradiol benzoate (EB,

2

,

ug/day)

MER-25 (5 mg/day), EB (2 ug/day) plus MER-25 (5 mg/day)
and oil vehicle on daily food intake during the third

week of treatment and body weight gain during 22 days of
+

treatment.
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-
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suppresion of body weight,

t

(8)=5.53, P<.001, which did

not differ significantly from that
produced by EB. The
5 mg dose of MER-25 did not clearly inhibit EB induced
sexual behavior.
It did however inhibit the uterina

weight increase (EB-treated:

558 mg vs. EB plus MER-25:

31k mg, t(7)=2128, p<.05, one-tailed) and completely

prevented uterine ballooning.
Part

MER-25 at the higher dose also showed no

2.

antagonism of estrogen-induced changes in weight regulation,
in contrast to the inhibition of all other somatic
and

behavioral parameters examined (Table

2 and

Figure 1).

The

combination of MER-25 and EB caused greater reduction of
food intake than either drug or hormone alone.

Animals

receiving both ate significantly less than the EB group,
t(l3)=i;. 55,

p <.05.

p<.001, or the MER-25 group, t(12)=2.19,

Body weight showed a similar additive effect of

the hormone and antiestrogen.

The EB plus MER-25 group lost

significantly more weight than the EB group, t(13)=3.97,
p-<.01, or the MER-25 group, t(12)=3.66,

length was slightly suppressed by EB,
and by MER-25,

t{

13)=2.

Ol;,

p<

Body

.01.

t( 1[|.)=2 .85,

pZ..05, one-tailed.

p<.05,

On the

other hand, all other estrogen sensitive parameters measured
|(howed inhibition by MER-25 and little or no estrogenic

effects from MER-25 aloneA^ The uterine weight response was

clearly inhibited,^

t( 13

cation u&s reversed.

)

=5. 75,

p<.001, and vaginal cornifi-

The vaginal response was interesting

in that all animals receiving EB plus MER-25 initially had

11

Table 2.

Effects of estradiol benzoate (EB,

2 nyg/day)

and

MER-25 (20 mg/day) alone or in combination on various
estrogen-sensitive parameters.
the mean)
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-

standard error of

111

CM
CM

CO

+

il

1

> r\

+

M
O

CM

•

+

•

+

1

IJ\

CM

CM
CM

tA

CM

lA

•

I

CO

II

rH

CM

vO

•

u>
CM

O

UN

+

•

CM

+

+

1

CO

1

•

1

1

CM

•

CM

0^

H

CM

rH
•

•

o

vO

H

S

II

C
•

vn
CM

+

fH

+

«

CM

O

1

H

+

1

H

+

1

1

*
•

O

O

vO

c^

•

•

•

•

H

CM
CM

CM

H•

iH

iH

+
•

+

W
rH

CO
•

II

d

w

(H

+

1

+

o

O
O

CM

rH

vO

C^
•

+

1

vO
vO

O
•

CM
CM

•

CM

C\]

1

•

H

+

1

J•

+

c^

rH

CM
iH

CO

•

H

'd
<D

•H
<M
•H

g
O

O

o
o
a

p

•>

bO

•«

O

•P
J5
tiD

•H

ai
<D

CO

<D

rH
erf

•H
<D
4->

t3

O O

•H

>
f.

S
o

CO*

>

<D

erf

erf

-p

s:

M

®
© o

«

:3

®

<D

PQ bO

O

xi

o

iH

?H

erf

-H

erf

Ph

iH

CQ

d +
X CQ

W

•H

0)

X

W

C0>^

0)

'd

erf

erf

bO
•H

\bO
-p

Mc

PQ

c

trf

C

-P

Tt

.H
Zi

l»

O

f:,

>--^

•H
bO

>

•H

®

erf

d

o
PQ

O
O

13

Figure

1.

Effect of estradiol benzoate (EB, 2 ug/day)

and MER-25 (20 mg/day) alone or in combination on
body weight and food intake of ovariectomized female
rats.

Arrow indicates beginning of treatment.
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comified smears within

3

days of treatment but the smears

contained only diestrous leucocytes
after 5-6 days of
treatment. Similar delayed inhibition
has been reported
for another antagonist, ICI
k^.klk (Emmens, 1971). Smears
of animals receiving only MER-25
has predominantly leuco-

cytes and occasional scattered nucleated
and cornified
cells.

Sexual behavior was also inhibited by this
dose of

MER-25, whether induced by EB alone, t(13)=1.88,
p
one- tailed, or EB facilitated by progesterone,
t(l3)=2.92,
p A.05.

EXPERIMENT 2.

TRANSIENT REDUCTION OF FOOD INTAKE AND

PERMANEITT REDUCTION OF BODY WEIGHT BY MER-25

Part

1

of this experiment was designed to
demonstrate

that MER-25 does depress food intake and body
weight in

OVX rats and to determine whether the reduction of
food
intake by MER-25 is transient, as estradiol- induced
hypo-

phagia is.

Part 2 determined the minimum effective dose

of MER-25 required to decrease food intake and body weight.

Procedure
Part 1.

Twelve female rats weighing approximately

250 g were ovariectomized and allowed

intake to restabilize.

lj.2

days for food

They were then divided into two

groups (n=6) balanced according to baseline food intake

and body weight and injected daily with 5 mg MER-25 in
0.1 cc sesame oil or with the vehicle alone.

Pood intake

was measured daily and body weight was measured every

third day.
Part 2.

Injections were continued for 32 days.

Thirty-eight female rats were ovariectomized

18 days prior to the beginning of treatment.

or n=8) received either MER-25 (5 mg,

1 mg,

Groups (n=7
500 ug or 100

ug) or iol vehicle daily for 20 days.

Results
Part 1.

Food intake was significantly depressed by

MER-25 during days 5-21, t(10)=3.25, P<.01, (Figure 2).
Over the course of treatment eating returned to control
levels.

During the final 10 days MER-25 treated animals

17

Figure 2.

Effect of the antiestrogen MER-25 (5 mg/day)

and oil vehicle on body weight and food intake of

ovariectomized female rats.
beginning of treatment.

Arrow indicates

19

ate an average of 26.6 g/day and
controls ate 27.3 g/day,
t(10)=0.97, £<.35. All MER-25 treated
animals increased

their food intake from the first 16 days to
the last 10
days, t(5)=3.09, ^-t.OS, and during the last
10

days did

not differ significantly from their own baselines
(27.5
g/day compared to 26.6 g/day, t(5)=0.73,
R<^lvS). However,
the body weight of MER-25 animals remained constant
and at

the end of treatment they had gained significantly
less

than controls,

Part 2.

t^(

10)=i|..[j.8,

£<.01.

Pood intake during days 6-20, computed as a

percentage of baseline food intake, was significantly lower
for the 5 mg MER-25 group compared to the oil-injected
controls, t_(13)=2.63,

£^.05.

The final body weight,

computed as a percentage of baseline, was also lower for
the 5 mg MER-25 group compared to oil controls,
I1..2I,

2^.01.

t_(13) =

One mg/day of MER-25 was totally ineffective

in decreasing eating and body weight, as were the 500 ug

and 100 ug doses.

The 5 mg MER-25 group received injections

for an additional I6 days, and its mean food intake returned
to approximately that of the control group by the 31st day.

EXPERIMMT

3.

ATTENUATION OF MER- 25- INDUCED REDUCTION

OF FOOD INTAKE AND BODY WEIGHT BY CONCURRENT

PROGESTERONE INJECTIONS
Since es tradiol-induced suppression of food intake

is

inhibited by progesterone, the effects of progesterone
on

MER-25-induced changes in food intake were investigated.
Both long-term ovariectomized rats whose weight had

plateaued and recently ovariectomized rats that were still
hyperphagic were tested.
Procedure
Part 1,

allowed

1^2

Eighteen female rats were ovariectomized and

days for food intake and body weight stabiliza-

Daily injections of oil, 5 mg MER-25, or 5 mg MER-25

tion.

plus 5 mg progesterone (n's = 6) were administered for 32
days.

Part 2.

Seventeen female rats weighing an average of

250 g were ovariectomized.

The following day injections

were begun of oil (n=5), 5 mg MER-25 (n=6) or 5 mg MER-25
plus 5

nig

progesterone (n=6).

The oil controls were con-

currently controls for Experiment

1,

Part 1,

Injections

were continued for 22 days.
Results
Part

1.

Over the 32 day period, progesterone caused

a reversal of the effects of MER-25 on body weight since
the progesterone plus MER-25 group gained significantly

more than the MER-25 group (Table 3), t.(10)=2.83, £-t.05.
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The effects of progesterone on MER- 25- induced reduction in

food intake were suggestive but not statistically reliable.

During the third week of treatment when MER-25 suppression
of food intake was maximal, t_(10)=3.91,

^<.01, progesterone

failed to clearly reverse the effect of MER-25, l(10)=1.55.

Part 2.

In recently ovariectomized females progesterone

countered the effects of MER-25 on both food intake and
body weight (Table 3).

During the third week of treatment,

the MER-25 plus progesterone group ate more than the MER-25

group, t{10)=1.97, £.^.05, one-tailed.

The effects of

MER-25 on body weight were again attenuated by progesterone.
Over the course of treamtnet the MER-25 group gained less
than the MER-25 plus progesterone group, t_(10)=l,82, £-C.05,
one-tailed.
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Table 3.

Effects of MER-25 (5nig/day), MER-25 (5 mg/day)

plus progesterone (5 mg/day), and oil vehicle on daily

food intake during the third week of treatment and body

weight gain during treatment.
ovariectomized
for 32 days.

1^2

In Part

1

females were

days prior to treatment and injected

In Part

2

females were ovariectomized one

day prior to treatment and injected for 22 days.
-

standard error of the mean)

(Mean

'
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EXPERIMENT

I4..

SEX DIFFERENCE IN RESPONSIVENESS
TO MER-25

.

Since estradiol is more effective in suppressing food
intake and body weight in famales than in males (Gentry
and Wade, 1976b), this experiment examined the possibility
of a sex difference in responsiveness to MER-25.

To

avoid confounding weight differences with sex differences,
two groups of females were used, one of comparable age to
the males and one of comparable body weight.

Procedure

Eight male rats castrated

3-i|.

weeks prior to the

beginning of treatment averaged 338 g in body weight.

The

ten light females of comparable age were ovariectomized
15 days before treatment and averaged 291 g when injections

began.
3

The eight heavy females had been ovariectomized

months earlier and weighed an average of 352

g.

Half

of the animals in each group were injected daily with

oil and the other half with 10 mg MER-25 for 28 days.

Results
A comparison of same age castrated males

ajid

females

indicated that MER-25 affected the body weight of females

more than males (Figure

3;

an overall analysis of variance

was performed on percentage weight change during 28 days

of treatment and subsequent two-way analysis of males and

light females resulted in a significant Sex X Drug interaction, F(l,20)=l|.53, £<.05).

Males and females of the

25

Figure

3.

Effects of MER-25 (10 mg/day) and oil vehicle

on body weight of castrated male rats, ovariectomized

female rats of comparable age (light females), and

ovariectomized female rats of comparable weight
(heavy females).
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same initial weight appeared to be comparably
affected;
the initial weight appeared to be
comparably affected; the
females showed a decrease in weight whereas
the males'

weight gain only slowed, but in comparison with
their
own controls there was no sex difference.

The sex

difference in the effects of MER-25 on food intake
was less
ambiguous. Females were more strongly affected than
males,

regardless of initial body weight (Figure

[j.) .

Analysis

was performed on mean food intake during the first 10
days
of treatment as a percentage of baseline.

Both light and

heavy females showed greater inhibition of food intake than
males (interaction term for males vs. light females, F(l,20)
=11.1^0, £-A.01;

interaction for males vs. heavy females,

F(l,20)=8.85, p<.01).

During the first 10 days of injec-

tions the MER-25 treated males ate 6^ less than their baseline, MER-25 treated light females ate 17^ less than their

baseline, and MER-25 treated heavy females ate 36^ less than

their baseline.

28

Figure

l^..

Effect of MER-25 (10 mg/day) and oil vehicle

on food intake of castrated male rats, ovariectomized

female rats of comparable age (light females) and

ovariectomized female rats of comparable weight
(heavy females).

Lower panel

is

the difference for

each condition from its respective control.
indicates beginning of treatment.

Arrow

110
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EXPERIMENT 5-

CONTROL FOR ILLNESS:

A LEARNED

AVERSION PARADIGM

An experiment was performed to ascertain whether
the
food intake reductions could be accounted for by
a general
illness possibly produced by MER-25 rather than a true

estrogenic effect.
Procedure
A learned aversion paradigm (Nachman, 1970) was

employed to investigate the possibility of the induction
of gastrointestinal discomfort.

Twenty OVX females were

adapted to water's being available 30 min./day, beginning
2

hours after the onset of dark.

Water intake was measured

to the nearest ml in calibrated Richter tubes, and food

intake was measured daily.

Saccharin flavored (0.1^)

water was presented as a novel taste, and followed at the
end of the 30 min. period by a subcutaneous injection of

lithium chloride (3.0 mEq/kg, i.e., 7.5 ml/kg of

.I4.

M

LiCl, n=7), MER-25 (125 mg/kg in oil, n=7), or oil (equi-

volume to the MER-25 injections, n=6).

On the following

two days water was presented, and on the third day a

second saccharin- in jection pairing was made.

Following

the second pairing, 9 days were allowed for the disappearance

of the direct effects of the MER-25 (a food intake decrease),
so that any learned effects would be measured rather than

direct drug effects.

The LiCl group controlled for the
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possibility that a learned aversion would fade
during this
time.

Results

MER-25 failed to produce a learned aversion to the
taste of saccharin after one or two pairings (Figure
5);
the oil and MER-25 groups drank virtually identical
amounts
in the two tests (21.0 vs. 19.8 ml on the first test and

21.0 vs. 21.1 ml on the second test.

LiCl in the same

paradigm produced a highly significant reduction in saccharin-

water intake on both test, i(ll)=6.99, p-^.OOl and t(ll) =
12.50, p^.OOl.

The dose of MER-25 was approximately 10

times the daily dose required to reduce food intake, and

caused a significant reduction in food intake after both
injections.

The change of food intake of oil and MER-25

treated rats for the two days pre- and post-injections

differed significantly,

t ( ll)i|..

614.,

p-^.OOl.

After the

second injections, food intake remained depressed for 6
days, t(ll)2.11, p^.05, one-tailed.

Body weight was also

clearly affected after the second injection; final body

weight of oil and MER-25 injected rats differed significantly,
t(ll)=3.59, p^.Ol.

Water intake was not reliably affected.

32

Figure 5.

Effects of two injections (Inj) of oil, MER-25

(125 mg/kg), or lithium chloride (LiCl, 2.0 mEq/kg)

following 30 min. presentations of saccharin-flavored

water (S, 0.1^ saccharin).
intake.

Upper panel

is

food

Lower panel is consumibion during daily 30

minute periods of unflavored water (connected by
solid lines) or saccharin-flavored water (indicated

by arrows and connected by dotted lines).

EXPERIMENT

6.

CENTRAL EFFECTS OF MER-25 ON EATING

This experiment determined whether an antiestrogen

implanted in the hypothalamus would produce effects
on
eating similar to those produced by estradiol.
Procedure

Female rats were ovariectomized and later stereo-

taxically implanted with bilateral, concentric double-

walled stainless steel cannulas (2? inner gauge, and 22
outer gauge).

Operations were performed under sodium

pentobarbital anesthesia.

Cannulas were aimed just dorsal

to the ventromedial hypothalamus, anterior hypothalamus

(AH), or preoptic area (PCA).

After recovery and the

recording of a stable baseline of food intake, the inner
cannulas were removed and crystalline MER-25, cholesterol,

estradiol or EB was tamped into the lumen.

The chemical

was left in place for three days, and then the inner

cannulas were removed and clea

;ied

by cumbustion.

After

at least a week of restabilized baseline, another chemical

was implanted for an additional three days.

All rats

received at least MER-25 and cholesterol in random order.

Pood intake was measured daily to the nearest

.1 g.

Results

An animal was considered to have responded to a
treatment if its mean food intake during the three days

following implantation of the chemical was at least 10^
less than its food intake during the three days prior to

Implantation.

Four animals were eliminated from analysis
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because they responded to cholesterol (two VMH and
two AH
placements); a fifth animal was eliminated because of

hyperphagia apparently due to mechanical damage of the VMH.
A total of 10 animals responded to MER-25 but not to
cholesterol.

Histological examination indicated that in

6 of

these the tips of the cannulas had been located in or dorsal
to the VMH (Figure 6); a seventh effective placement was

at the same rostral-caudal plane but more lateral.

ments of the other

3

Place-

effective cannulas were in the POA

and the bed nucleus of the stria terminalis (POA-ST).

There were 5 ineffective POA-ST placements and 6 ineffective

anterior hypothalamic placements.

One animal had a place-

ment close to the arcuate nuclei and failed to respond to
MER-25.

Statistically, responses to MER-25 implanted in

the ventral hypothalsimus differed from those in the AH-POA-

ST (Fisher test, p^.OOl).

Four of the animals with VMH placements effective for

MER-25 were implanted with EB or estradiol; all four decreased
their food intake.

EB was also effective in the arcuate

placement which did not respond to MER-25.

Of the remaining

non-responders to MER-25, 6 were implanted with EB or
estradiol, and none responded by decreasing food intake.
The animals with effective placements in the ventral hypotha-

lamus decreased their food intake an average of 22^ to

MER-25 and the average response to estradiol or EB was a
19% reduction in food intake.

The three effective place-

ments in the POA-ST caused greater reductions, averaging
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Figure 6.

Location of implants of antiestrogen which

affected food intake in female rats.

Squares indicate

locations of bilateral implants of MER-25 which caused
a reduction of food intake of at least 10% for the

three days following implantation and showed no

response to cholesterol implantation.

Circles

indicate location of implants which did not alter
food intake.

Coronal planes of the rat diencephalon

are adapted from Pellegrino and Cushman,

responded to MER-25
OnO response to MER-25

EXPERIMENT

BODY WEIGHT EFFECTS OP MER-25
INDEPENDENT

?.

OP POOD INTAKE CHANGES:

A PAIR-FEEDING STUDY

This experiment determined whether
some of

tte

weight reduction caused by EB or MER-25
treatment
by factors other than reduction of food

body

is

mediated

intake.

Procedure

Twenty-five female rats were ovariectomized
15 days

prior to treatment.

Twenty females were divided into 10

pairs matched for body weight, and these 10 pairs were

divided into

2 groups

weight 281 g for all

balanced for body weight (mean body
I4.

groups).

One member of each pair

in group 1 received 5 ug of EB and was fed ad lib; the
other

member received oil injections and was allocated the amount
of food consumed on the previous day by its matched pair.

Similarly, five animals received 10 mg MER-25 daily and food

ad lib while a pair-fed group received oil injections and

individually tailored food allotments.

The five remaining

rats (average body weight 270 g) received oil injections

and ad lib food.

Body weight was measured every third day

and injections were continued for 33 days.

Results

Both EB and MER-25 caused weight reductions which could
not be simulated simply by food restriction in controls
(Figure 7).

Whereas animals injected with EB increased

body weight by

animals which ate the same amount but

were injected with oil increased body weight by lS%, paired
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ure 7.

Percentage body weight changes of ovariectomized

female rats treated with 5 ug estradiol benzoate (EB)/
day, IQ mg MER-25/day or with the sesame oil vehicle.

Two additional groups were treated with sesame oil and

pair- fed with either the EB- or MER-25- treated groups.
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t{k)=9.3S, p<C.01.

Neither of the pair-fed groups differed

significantly from the ad lib oil controls.
It could be argued that a metabolic derangement or
som.

other consequences of pair-feeding, per se, prevented the

expected weight losses of the pair- fed rats.

However, it

has been shown that a pair-feeding regimen similar to ours

produces weight losses, not gains, in rats (Rider and Chow,
1971).

Thus, the body weight differences are not likely

artifacts of a pair-feeding procedure.

EXPERIMENT

8.

EFFECTS OF MER-25 IN GERBILS

Female Mongolian gerbils are unusual in that
they
respoid to EB injections by increasing eating and
body
weight (Maass and Wade, unpublished); they therefore
provide a particularly good opportunity to test the

generality of the estrogenic effect of MER-25 on eating.
If gerbils responded to MER-25 by increasing their food

intake, it would demonstrate that MER-25 can produce

estrogenic effects on food intake which cannot be con-

founded by hypothetical toxic effects.
Procedure
Five weeks after ovariectomy 30 adult gerbils were

divided into four groups.

Daily subcutaneous injections

of the following compounds were administered for four

weeks:

k mg MER-25 (M; n=7),

gesterone (MP; n=8),

l\.

I;

mg MER-25 plus

mg MER-25 plus

2

bination with

P

mg pro-

ug EB plus 1 mg P

(MEP; n=7), or the sesame oil vehicle (0; n=8).

djections were in 0.1 ml.

1

All

The effects of MER-25 in com-

and EP were of interest, since in OVX

gerbils progesterone augments the effects of EB on eating

while having little or no effect when given alone (Maass
fiind

Wade, unpublished).

The MP group might facilitate

detection of an estrogenic effect of MER-25, whereas the
MEP group would optimize the chances of observing an anta-

gonistic action of MER-25.

Analyses were performed on the

difference between individuals' mean food intake or body

i+3

weight during the second 2-week period
of treatment and a
2-week pretreatment baseline. Data from
Maass and Wade
(unpublished) of additional control animals

{n=6) and animals

given progesterone (1 mg; n=6) were added
to the analysis
to allow two-way analysis of variance
of the
0,

M, MP,

and

P groups.

Data of groups receiving E and EP are presented
for comparison.

Results
The results indicate that MER-25 (M and MP)
causes

increasing eating and body weight in OVX gerbils, P(l,31)=
i;.778,
is

P-C.05, and P( 1, 31) =l4..9i4i,

p<.05

(Table

i^)

This

.

presumably an estrogenic effect, since estradiol benzoate

also increases eating and body weight in gerbils.

Pro-

gesterone did not have any effect alone and did not interact

with the effect of MER-25 on either measure.

The three

compounds together (MEP) markedly increased eating and body
weight, t(19)=5.227, p^.OOl and t(19)=6. 525,

p<

.001.

There was no evidence of an es trogen-stntagonizing effect on
these measures from a comparison of the MEP and EP groups.
The effects of the ovarian hormones and the antiestrogen

on body weight continued as long as treatment continued,
aid after treatment was discontinued the animals' body

weights returned to control levels within seven weeks.

.

kh

TABLE

I4..

POOD INTAKE AND BODY WEIGHT OP MONGOLIAN GERBILS

TREATED WITH THE ANTIESTROGEN MER-25 AND OVARIAN
HORMONES

Ovariectomized gerbils were given daily injections of MER-25
(M,

ij.

mg), MER-25 plus progesterone (MP, k mg plus 1 mg),

MER-25 plus estradiol benzoate plus progesterone (MEP,
plus 2 ug plus 1 mg), or sesame oil vehicle.

Data are

computed as change from 2 weeks of baseline to weeks

2-I|.

of treatment.

*Data of similarly treated animals from Maass and Wade
(unpublished)
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DISCUSSION

Estradiol and the antiestrogen MER-25 have similar
effects on eating and body weight in rats and gerbils:
(1)
is

The food intake reduction during EB or MER-25 treatment

transient; eating remains depressed for a period of days

and then gradually returns to control levels, but body

weight remains lower than controls (Experiment 2).

The

time-course of the reinstatement of normal food intake
levels varies, depending on the dose of MER-25 and pre-

treatment body weight, but is approximately 30 days, similar
to that found for EB treatment (Wade, 1975).
(2) Progesterone inhibited the effects of MER-25 as it

does those of EB (Experiment 3).

females 5

nig

In recently ovariectomized

of progesterone caused a S0% inhibition of

the food intake suppression by MER-25, comparable to the

effects of 5

nig

progesterone counteracting

(Gentry and Wade, 1976a).

2 ug of

EB

In heavier long-term ovariec-

tomized females progesterone produced a similar, but not

statistically significant, effect on food intake, and the
effect of MER-25 on body weight was significantly attenuated

by progesterone,
(3)

MER-25

is

more effective in female rats than in

male rats in causing food intake reduction (Experijnent

i^.)

There are similar sex differences in the effectiveness of

EB for a variety of behaviors including eating (Gentry and
Wade, 1976b; Pfaff, 1970).

The sex difference in food

^7

intake effects was clear for either light
or heavy females
compared to males, but the sex difference
for body weight
effects was apparent only for the light females
compared
to males.
(k) When rats were implanted intracerebrally with the

antiestrogen, the medial basal hypothalamus was an
area
in which MER-25 produced estrogenic actions
on eating.

For

all 11 animals implanted with the antiestrogen and with

estradiol at another time, there was a high correlation
between responses to the antiestrogen and to the estrogen.

Although the POA-ST placements were not tested with estradiol,
it is less likely that the 3 responsive sites were actually

estrogenic sites, since there were 5 ineffective implants in

similar sites.

The finding that the most consistently

effective placements were in the medial basal hypothalamus
confirms earlier reports on the localization of estradiol's
actions on food intake (Beatty et al.,

197I|.;

Jankowiak and

Stern, 197i;; Wade and Zucker, 1970).
(5) Both EB and MER-25 produce some body weight reduc-

tions by means independent of their alterations in food

intake (Experiment 7).
(6) The results of Experiment 8 with gerbils extend

across species the parallel between the effects of EB and

MER-25 on food intake.

In rats estrogens and MER-25

decrease food intake and body weight, whereas in gerbils
the estrogenic effect is indicated by the increases in

food intake and body weight during treatment with MER-25.

1+8

For a number of reasons it is highly
unlikely that
MER-25 is having its effects on eating
and body weight
by inducing a nonspecific malaise:
(1) An aversion to the novel flavor of saccharin
was

not induced by twice pairing it with a very
high dose of

MER-25 (Experiment 5).

The effectiveness of the LiCl

treatment suggests that if any aversion had been created
by MER-25 it would still have been evident at the final
testing.
(2)

MER-25 does not alter spontaneous running wheel

activity levels of nonhormone-treated rats.

Although MER-25

reduces estradiol- or testosterone-induced activity in male
rats, it has no effect on the spontaneous activity of

castrated males (Roy and Wade, 1975).

In that experiment

MER-25 did reduce the males' food intake; during the first
k days of treatment MER-25 treated rats averaged Qk% of
their baseline, t{8)=2.i;0,
(3)

p-^.

.05 (unpublished data).

The food intake reduction is transient while the

body weight reduction is permanent.

Within each experiment there was a tendency for

MER-25 to have greater effects in heavier rats; for example,
in Experiment

l|.

there was a high correlation between baseline

weight and weight loss (r=.70 for long-term OVX females and
r=,82 for recently OVX females).

This suggests a weight

regulatory effect rather than an illness effect, since the
latter explanation would product greater effects in lighter
rats because they receive relatively higher doses.

k9
(5) The increases in eating and body weight
produced
by MER-25 in gerbils (Experiment 8) also
suggest that the
effects in rats are specifically estrogenic.

(6) Finally, MER-25 can reduce food intake when

implanted durectly into the hypothalamus
(Experiment 6).
These data support the hypothesis that MER-25 is
acting

as

an estrogen to lower food intake and body weight
rather
than by causing general illness.

The results of hypothalamic

implants indicate that the effects on eating of either MER-25
or EB are centrally mediated, but pair-feeding studies

indicate that there are additional metabolic effects of

both agents which cause further loss of weight (Experiment
7).

MER-25 is totally ineffective in antagonizing the
effects of estradiol on eating and body weight (Experiment
1).

Niether 5 mg nor 20 mg of MER-25 attenuated the effects

of 2 ug of EB on eating and body weight at any time, yet
it inhibited Eb's effects on sexual behavior,

and vaginal smears.

uterine weight

The inhibition by MER-25 of these

responses is well-established (Lerner et al., 1958; Meyerson
and Lindstrom, 1968; Sodersten,

I97I4.)

.

Furthermore, MER-25

alone had no agonistic effects on these noneating parameters.
This is consistent with other reports of the absence of or

minimal agonistic effects on these measures (Komisaruk and
Beyer, 1972; Lerner,
1971).

1961;;

Lerner et al., 1958; Torenius,

There have been no reports of any induction of

50

female sexual behavior by MER-25, despite a wide variety
of

doses and timing routines tested (Meyerson and Lindstrom,
1968; Sodersten, 1971+; Hoy, unpublished data) and no

evidence of an estrogenic effect on spontaneous activity
(Roy and Wade, 1975).

In gerbils, the similar increases

in eating and body weight of the MEP and EP groups support
the idea that MER-25 does not have any estrogen-antagonizing

effects on these measures.
Thus, the estrogen-sensitive systems affecting eating

and weight regulation differ biochemically from most other

behavioral and peripheral systems, as reflected by the

difference in responses to antiestrogens •

The distinction

is not simply that the antiestrogen is estrogenic,

since

other systems may sometimes exhibit some agonistic response
under the appropriate conditions.

The distinction is that

the eating system shows a fully estrogenic response to the

antiestrogen, so that no inhibition of estradiol's action
can be demonstrated.

Preliminary evidence indicates that

the other triphenyl antiestrogens are similarly estrogenic

with respect to eating, including CI-628 (Powers, personal
communication) and nafoxidine (Roy, unpublished data).
Recent reports (Baum and Vreeburg, 1976; Sodersten,

197i4-)

indicate that MER-25 may also be solely "estrogenic" with

respect to masculine sexual behavior.

Mounting behavior is

induced by EB or MER-25 in castrated rats of either sex,
and the drug fails to inhibit EB- induced mounting in

•

females or testosterone-induced mounting
in males.

Thus,

estrogens are able to influence behavior by
at least two
different mechanisms as indicated by the responses
of

various behaviors to antiestrogens .

The manner in which

estradiol's actions on the eating system differ from
its

actions on other behavioral systems is unknown, but
would

presumably be related to the mechanism of action of the
antiestrogens

PART^II.. THE EFFECTS OF ANTIESTROGENS ON THE UPTAKE
OF

H-ESTRADIOL IN THE CENTRAL NERVOUS SYSTEM AND
FEMALE SEXUAL BEHAVIOR

Antiestrogens may produce their estrogen-antagonizing
effects by forming relatively ineffective complexes with

estrogen receptors, thereby lowering the estradiol uptake
into target tissues.

Their estrogenic actions could also

be mediated by interactions with estrogen receptors.

It

is appropriate to begin an investigation of either the

estrogen-antagonizing actions or estrogenic actions of
antiestrogens by determining whether or not they interact

with estrogen receptors, as indicated by competition with
estradiol for binding sites.

Competition for estrogen

receptors of peripheral tissues has been clearly demonstrated
(Black and Kraay, 1973; Jensen et al., I966; Stone,

1961].;

Terenius, 1971; Whalen and Gorzalka, 1973), but reports

concerning the effects of antiestrogens on brain estradiol
uptake have been less consistent.

Hypothalamic uptake of

estradiol was reportedly not reduced by the antiestrogen
CI-628 (Perry et al., 1973), even in a paradigm similar to
one in which estrous behavior was inhibited (Whalen and

Gorzalka, 1973).

However, there have been recent reports

of in vivo competition by CI-628 in the cytosol fraction

(Whalen et al., 1975) and nuclear fraction (Chazal et al.,
1975; Luttge et al., 1976) of the hypothalamus.

Inhibition

in the nuclear fraction may be particularly important if
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estradiol acts by similar mechanisms in the brain
and uterus.
Nafoxidine is an antiestrogen widely used to
study mechanisms
of estrogen antagonism in the uterus (Capony
and Rochefort,
1975; Clark et al., 1971;; Jensen et al., 1966; Katzenellen-

bogen and Ferguson, 1975).

Its behavioral effects have

not been studied, and there have been positive (Eisenfeld
aid Axelrod,

I967) and negative (Jensen et al., I966) reports

on its inhibition of hypothalamic estradiol uptake.

The

antiestrogen clomiphene competes with estradiol in the
hypothalamus in vivo (Eisenfeld and Axelrod, 1967; Kato
et al.,

1968; Maurer and Woolley, 1971), but conclusions

from these data regarding the mechanisms of estrogenantagonism must be limited, since these studies have
employed racemic clomiphene, one isomer of which

estrogen (Ross et al., 1973).

is

a full

MER-25 is a commonly used

antiestrogen in studies of sexual behavior (Baum and Vreeburg,
1976; Komisaruk and Beyer, 1972; Meyerson and Lindstrom,

1968; Sodersten,

197)-|)

.

In vitro MER-25 has a low affinity

for hypothalamic cytosol estrogen receptors (Barley et al.,
1971;),

but it has not been tested for its effects on hypo-

thalamic estradiol uptake

_in

vivo .

In order to clarify the relationship between estradiol

binding in the brain and its behavioral actions, the effects
of three anties trogens (MER-25, CI-628, and nafoxidine) on
the in vivo ^H-estradiol uptake and retention were determined
in cell nuclear fractions of regions of the brain and

.

pituitary.

In parallel studies their ability to
block

estradiol-induced female sexual behavior was examined.
Method
H-estradiol Uptake

.

Mature female Sprague-Dawley

rats (Charles River Breeding Laboratories), housed in
grou
cages under a 12:12 lighting cycle, were ovariectomized
at

least four days prior to uptake studies.

Groups were

matched for body weights.
6,

]J - H-estradiol-17B (specific activity: 91.3 Ci/mM;

New England Nuclear) was dissolved in 20% ethanol.

Injec-

tions of 100 uCi (.3 ug) in .2 ml were administered in the

femoral vein under light metho^yf lurane (Metofane) anesthesia.

MER-25

(1+0

nofoxidine

mg,
(I4.

in sesame oil), CI-628

mg,

(i^.

mg,

in saline),

in sesame oil), or sesame oil was injected

intraperitoneally at various times before or after the
^H-estradiol injection.
on the finding that

i+O

Doses of antiestrogens were based
mg of MER-25 are required to inhibit

mating in intact female rats, (Shirley, Polinsky, and
Schwartz, I968) and CI-628 and nafoxidine have approximately
10 times greater affinity than MER-25 for uterine estradiol

receptors (Black and Kraay, 1973; Terenius, 1971).

At

various times after the estradiol injection, rats were

anesthetized with sodium pentobarbital (Nembutal), a blood
sample was taken, and the animals were perfused with cold
saline
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Cell nuclei were isolated by the method
of Zigmond and
McEwen (1970) with modifications (Gentry,
Wade, and Roy,

All samples were homogenized in cold
buffer con-

1976).

taining .32 M sucrose, .25^ Triton X-100,
K^PO^, pH 6.5.

homogenate.

3

mM MgCl^, ImM

An aliquot of this was taken as the whole

The remainder was centrifuged at 850

^

for 10

min., and washed once in the same buffer without
Triton.

After purification of the nuclei by centrif ugation through

buffer containing
with

X

3

[j.

2

M sucrose, radioactivity was extracted

ml toluene-based scintillation cocktail.

Protein

was precipitated with ethanol and estimated by the method
of Lowry

et.

al.

(1951).

of tissue to plasma, i,e .

Results are expressed as the ratio

disint./min./mg. protein divided

.

by bloo.d plasma disint./min./ ul.

All differences reported

are significant at the .05 level or beyond using the Student's

i-test.

The results were the same whether or not the data

were standardized by dividing by plasma levels of radio-

activity.
In vitro Dissociation

.

For this experiment animals

were treated as above with sesame oil or
hours prior to

3

l\.0

mg MER-25

2

H-estradiol and were killed 2 hours after

the estradiol injection.

The nuclei were isolated as

above, but POA and hypothalajnic sections were pooled.

Isolated nuclei from 8 animals per group were resuspended
in the .32 M sucrose buffer without Triton and incubated
o

at 27

•

Aliquots were taken at various times, washed

3

.
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times in cold buffer, and the radioactivity
extracted.
The supernatant from the washes
(radioactivity not bound
to nuclei) was counted in toluene
scintillation cocktail
containing 33^ Triton X-100. Results are
expressed as the

percentage of the total radioactivity (supernatant
disint./
min. plus pellet disint ./rain. ) found in the
pelleted

nuclei

(percent bound)

Behavioral Testing;.

Three ug of unesterified estradiol-

17B in 20^ ethanol were injected intravenously

hours before -testing.

21;

or 36

Progesterone (1 mg) was injected

subcutajieously 5 hours prior to testing.

Groups were matched

for behavioral sensitivity to estradiol.

Anties trogens (MER-25,

kO mg; CI-628,

mg; nafoxidine,

i^.

mg) or vehicle were

injected intraperitoneally 2 hours prior to the estradiol
injection, except for one study in which MER-25

ik-O

mg) was

injected 12 hours prior to the estradiol injection.

The

female was placed into a circular arena, and then two

sexually experienced males were placed in the arena and

allowed 10 vigorous mounts.

Lordosis responding was rated

on a 3-point scale after Powers and Valenstein (1972),

3

being the highest score and indicating extreme dorsoflexion
of the head and rump.

Observations were made without know-

ledge of the treatment received by particular animals.

Animals used in the MER-25 studies were tested repeatedly

with at least one week intervening between sessions and
alternating control and experimental treatments, without
detriment to the lordosis responding of control groups.
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Student's t-test was used to determine statistical
significance.

The results were identical when the data were

expressed as lordosis quotients.

EXPERIMENT
2

9.

EFFECTS OF ANTIESTROGENS INJECTED

HOURS PRIOR TO ^H-ESTRADIOL ON UPTAKE IN

WHOLE HOMOGENATES AND CELL NUCLEI
OP THE BRAIN
Two -hour uptake.

When uptake was examined
3

2

hours after the injection of

H-estradiol, the antiestrogen CI-628 most effectively

reduced levels of radioactivity (Figure 8).

Uptake was

reduced in the whole homogenates of pituitary and all three

brain areas.

Nuclear ^H-estradiol binding was reduced even

more than whole homogenate binding, with

99/^

inhibition in

the pituitary, 79^ inhibition in the hypothalamus, 8?^ inhi-

bition in the POA, and

59/^

inhibition in the cerebral cortex.

Nafoxidine also effectively reduced ^H-estradiol uptake
in the pituitary and brain (Figure 8).

less effective than CI-628.

It was somewhat

Nafoxidine inhibited

H-estradiol

uptake in the nuclear fraction by 88^ in the pituitary,
in the hypothalamus, and

in the POA.

MER-25 on the

other hand, failed to inhibit the 2-hour uptake of

3

H-estra-

diol into any of the brain areas, even while inhibiting

pituitary uptake by

62,%

in the whole homogenate and 70%

in the nuclear fraction (Figure 8).

There was also no

inhibition of ^H-estradiol levels in hypothalamic cytosol
from similarly treated animals.

Six-hour and twelve-hour retention.
It has been suggested that for uterine tissue the low

levels of estradiol which are bound in cell nuclei for long
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Figure

Effects of anties trogens injected

8.

hours prior

2

^-estradiol on levels of radioactivity

to

in sub-

celular fractions of brain tissues and pituitary
12 hours after the ^H-estradiol injection.

values

-

2

or

Mean

S.E. of the concentration of tissue radio-

activity relative to plasma radioactivity are presented
for whole homogenate and cell nuclear fractions of
cerebral cortex (CTX), hypothalamus (HTH), preoptic

area-septum (POA), and pituitary (PIT).
toneal injections of sesame oil vehicle
and n=6 for 12 hour), MER-25

{^.0

(i^.

(i|

for 2-hour

{n=[|.

mg in oil,

2-hour and n=6 for 12-hour), CI-628
n=l^

Intraperi-

n^ii

mg in saline,

for 2-hour and n=3 for 12-hour), or nafoxidine

mg in oil,

n=i;

were administered

for 2-hour and
2

n=k.

for 12-hour)

hours prior to an intravenous

injection of 100 uCi (.3 ug) of ^H-estradiol.
^5-pZ.

for

.05,

-:t4:-p

<,01
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time intervals may be functionally
significant (Clark and
Peck, 1976).
We investigated levels of bound
radioactivity
at later time intervals after the injection
of ^H-es tradiol

without changing the 2-hour interval between the
antiestrogen and %-estradiol injections. At 6 hours after
the

injection of estradiol, MER-.25 still showed no evidence
of

inhibiting brain %-estradiol binding in either whole

homogenate or nuclear fractions, even through pituitary

nuclear radioactivity was reduced by 8l^,
Interestingly, by 12 hours after the ^H-estradiol

injection MER-25 had reduced radioactivity found in hypothalamic nuclei by 26^ and lowered POA nuclear radioactivity

by

(Figure 8).

Whole homogenate levels in brain

tissues, which were quite low at this time, were not affected

by MER-25.

Pituitary binding of estradiol at 12 hours was

reduced by MER-25 by

9irf

in whole homogenate and by 96^

in nuclei.

Comparison of 2-hour uptake and 12-hour retention.
In addition to the appearance of significant inhibition
of brain nuclear ^H-estradiol binding by MER-25 after a long

time interval, CI-628 and nafoxidine showed a greater

inhibition of nuclear binding at 12 hours than at

after the injection of estradiol.

2

hours

Figure 9 indicates that

when expressed as a percentage of control values, 12-hour
retention of

H-estradiol was affected more than 2-hour

uptake for all three anties trogens

.

Percentages at 12 hours

and 2 hours differed significantly for all samples except
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Figure

9.

Relative inhibition of -^H-estradiol retention in

cell nuclei at 12 hours vs. at 2 hours.

Data of

nuclear concentration of radioactivity from Figure
are expressed as percentage of control values at
the same time point.

Twelve-hour percentages are

significantly lower than 2-hour percentages for all
samples except CI-628 pituitary and hypothalamus.

8

NUCLEAR ESTRADIOL
(

Ti

ssue/PlQsma)

CI.628 HTH and CI-628 PIT.

CI-628 had already virtually

eliminated ^H-estradiol from pituitary nuclei
at

2

hours.

EXPERIMENT 10.

IN VITRO DISSOCIATION OF ^H-ESTRADIOL

PROM NUCLEI AFTER MER-25 TREATMENT
There are at least two possible explanations
of the
greater inhibition of 12-hour retention than 2-hour

uptake.

The first is that the anties trogens are somehow
altering

nuclear binding sites so that estradiol

is

less firmly

bound, causing the hormone to leave the nuclei faster in

antiestrogen-pretreated tissues.

The second is that continuing

competition of the estrogen and anties trogen occurs, and
the ratio of antiestrogen to estrogen might be greater at

later times.

The first possibility was assessed by examining

the 221 vitro dissociation of

H-estradiol from nuclei of

animals pretreated with MER-25 or oil and injected with

H-estradiol in the same paradigm as the above uptake
studies.

If MER-25 were altering the ability of the nuclei

to retain the ^H-estradiol, ^H-estradiol should dissociate

from nuclei of MER-25 pretreated animals faster than from
control nuclei.

At sacrifice 2 hours after the %-estradiol

injection there was again no inhibition of nuclear uptake
by MER-25 in the hypothalamus- POA.
of in vitro incubation

3

During 10 further hours

H-estradiol dissociated from nuclei

of the hypothalamus -POA at the same rate whether nuclei

were obtained from MER-25 treated animals or controls
(Figure 10).

Pituitary nuclei also showed similar rates

of in vitro dissociation of 3h -estradiol when isolated from

MER-25 pretreated or control nuclei.
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Figure 10.

In vitro dissociation of ^H-estradiol
from brain

cell nuclei.
(oil vehicle or

i|0

Animals were treated as in Figure

mg MER-25 injected

2

8

hours prior to .3

ug 3 H-estradiol) and nuclei prepared in the
same

manner except hypothalamus and preoptic area were
pooled; tissues from 8 animals were prepared together.
The isolated nuclei were resuspended in the .32 M

sucrose buffer and incubated at 27° for specified
timr;-^;

at these times aliquots of nuclei were removed

and washed three times.

Radioactivity was determined

in the supernatants and final pellet of the washes,

and results are expressed as percentage of total

radioactivity bound to the pelleted nuclei.
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IN

VITRO DISSOCIATION OF ^H-ESTRADIOL
FROM BRAIN CELL NUCLEI
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•
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CONTROL
MER-25

60

40

O
2
O
m

20

2

4

6

INCUBATION TIME,
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These results make the second possibility
more likely:
competition for nuclear binding is still occurrin;^
lon/^

after the initial peak of binding.

This would suggest that

the binding of estradiol to nuclei is a dynamic
process,

with estradiol dissociating and reassociating with
the
nuclei.

This interpretation was encouraged by examination

of a logarithmic plot of the uptake and retention of

H-estradiol in control and MER-25 treated animals (Figure
11).

The control groups deviate from the linearity which

characterizes simple second-order dissociation.

While the

statistical interaction of time and treatment was significant for all three tissues, a statistical analysis of the

nonlinear contribution to the control levels of estradiol
over time would require additional time points.

MER-25 may

have replaced dissociating estradiol complexes rather than

allowing the possibility of reassociation.

69

ure 11.

Effect of MER-25 on nuclear retention of ^H-

estradiol.

Data of animals given oil or

I4.0

mg MER-25

two hours prior to ^H-es tradiol and killed 2 hours
(n's=l;)

or 12 hours (n's=6) after the estradiol, and

animals given the same treatments and killed at 6 hours
(n's=3) are plotted in semilogarithmic coordinates.

The interaction of time and treatment is significant

for all three tissues.
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EFFECT OF MER-25 ON NUCLEAR RETENTION OF
^h-ESTRADIOL

TIME AFTER ^H-ESTRADIOL INJECTION, Hours

EXPERIMENT 11.

MER-25 ADMINISTERED 12 HOURS PRIOR TO
3

H- ESTRADIOL

It is possible that MER-25 failed to inhibit
2-hour

uptake simply because it was not in the brain soon
after
its injection and that the inhibition seen at
12 hours was

due to delayed competition with estradiol.

To test this

hypothesis, MER-25 was injected 12 hours prior to an intra-

venous injection of ^H-estradiol, and 2-hour uptake was

examined again.

In this paradigm uptake of

H-estradiol

at 2 hours was significantly inhibited by MER-25 in nuclei
of all brain samples and whole homogenates of the hypotha-

lamus and POA (Figure 12).

Pituitary nuclear optake was

reduced by 83^, hypothalamic nuclear uptake by

nuclear uptake by

1^0%,

1^1%,

POA

and cortical nuclear uptake by 31^.
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Figure 12.

Effect of 12-hour MER-25 pretreatment on 2-hour

uptake of

%-es tradiol

.

MER-25

([;0

mg; n=6) or oil

vehicle (n=6) was injected intraperitoneally 12 hours

prior to an intravenous injection of
estradiol.

Animals were killed

2

,3 ug of -^H-

hours later and

radioactivity measured in whole homogenate and nuclear
fractions of cortex, hypothalamus, preoptic areaseptum, and pituitary.

EFFECT OF 12 HOUR MER-25 PRETREATMENT
ON 2 HOUR ^H-ESTRADIOL UPTAKE
-

WHOLE HOMOGENATE

CTX

HTH

POA

PIT

.

EXPERIMENT 12.

DISPLACEMP2TT BY AN ANTIESTROGEN OP

^H-ESTRADIOL BOUND TO NUCLEI
A more direct test of the possibility that antiestrogens
can compete with normally exchanging estradiol was to

administer the antiestrogen subsequent to the peak of nuclear
estradiol binding and look for "displacement" of estradiol
at a later time.

Peak nuclear concentration of ^H-estradiol

occurs 1-2 hours after a

.3

ug intravenous injection (Mowles,

Ashkanazy, Mix, and Sheppard, 1971).

intraperitoneally

2

CI-628 was injected

hours following an intravenous injection

of ^H-estradiol, and the animals were sacrificed 12 hours

after the estradiol.

Radioactivity retained in the brain

at this time was greatly reduced by CI-628 (Figure I3)

CI-628 subsequent to estradiol reduced the binding of
estradiol in whole homogenate of the hypothalamus-POA by
^Sio

and reduced hypothalamic-POA nuclear binding by 83^.
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Figure 13

.

Displacement of

H-estradiol from the hypotha-

lamus by a subsequent injection of an anties trogen.

CI-628

mg; n=i;) or saline vehicle (n=i;) was injected

intraperitoneally

2

hours after an intravenous injection

3
of .3 ug -^H-estradiol.

Animals were killed 12 hours

after the estradiol injection, and radioactivity

measured in whole homogenate and nuclear fractions of
cerebral cortex (CTX) and pooled hypothalamus-preoptic

area-septum (HTH-POA).
-«-p

.05,

""'•-p

.01
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DISPLACEMENT OF 'h-ESTRAOIOL BY A
SUBSEQUENT INJECTION OF ANTIESTROGEN
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EXPERIMENT 13 .

INHIBITION OP ESTRADIOL- INDUCED

LORDOSIS BY ANTIESTROGENS
The inhibition of behavior paralleled the inhibition
of nuclear binding of estradiol.

Two-hour pretreatment

with CI-628 or nafoxidine, which produced substantial
reductions of nuclear estradiol levels, totally eliminated
female sexual behavior induced by an intravenous injection
of unesterified estradiol (Figure

li|)

The females were

.

active and readily mounted by the males, but they did not
display the lordosis reflex.

when injected

2

On the other hand, MER-25

hours prior to the estradiol injection,

failed to inhibit early uptake of estradiol and also completely failed to inhibit sexual behavior tested at
hours (Figure 15).

21;

There was also no significant inhibition

of sexual behavior when additional groups were tested at 36

hours after the estradiol injection.

When tested at

i|8

hours,

none of the 10 MER-25 treated animals was in heat, but only
i^.

of 8 control animals were even marginally in heat.

when MER-25 was injected 12 hours prior

However,

to the intravenous

estradiol injection, a paradigm in which brain uptake was
reduced, clear inhibition of es tradiol-induced sexual recep-

tivity was observed at

2i|

hours (Figure 15)

•
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'6

li;.

Inhibition of estradiol- induced female sexual

behavior by antiestrogens

.

Ovariectomized-hysterec-

tomized rats were given intraperitonel injections of
sesame oil (n^l^), CI-628

nafoxidine

(Ij.

mg in oil,

intravenous injection of

(i^

mg in saline;

n=i4.)

,

or

hours prior to an

n=l|)

2

3 ug

of unesterified estradiol.

At 19 hours after the estradiol, they were injected

subcutaneously with

1 rag

progesterone, and at

2I4.

hours tested for sexual receptivity with a vigorous
male.

The rating system is after Powers and Valenstein

(1972).

\
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INHIBITION OF ESTRADI OL - N DU CED
SEXUAL BEHAVIOR BY ANTIESTROGENS
I

2.0
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CONTROL
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Figure 1^.

Effect of antiestrogen MER-25 on estradiol-

induced female sexual receptivity.

Intraperitoneal

injections of oil vehicle or MER-25 (^0 mg in oil)

were administered either 2 hours or 12 hours prior to
an intravenous injection of

estradiol.
21].

1

3

ug of unesterified

Females were tested with males at either

hours or 3^ hours after the estradiol injection;

mg progesterone was injected subcutaneously 5 hours

prior to testing.

Oil or MER-25 injected

2

hours

prior to estradiol, for 2i;-hour test n's=3 and
for 36=hour test, n's=13 and

ii;

oil or MER-25

injected 12 hours prior to estradiol, n's=7 and 7.
*^'"P<»01
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EFFECT OF ANTIESTROGEN ON ESTRAD 10 L- NDUCED
RECEP Tl VITY
1

-

MER-25

2

HOURS BEFORE ESTRADIOL
oil

MER-25

12

HOURS

BEFORE ESTRADIOL

MER-25

* »

24 HOUR TEST

36 HOUR TEST

24 HOUR TEST

DISCUSSION
These results clearly establish that ant
ies trogens are
capable of inhibiting Vestradiol uptake in
the hypothalamus
and preoptic area of the rat brain. With CI-628,
inhibition
was most dramatic in the tissues with the
highest
uptake:

pituitary

POA

hypothalamus

unlabelled estradiol

is

cortex.

Competition by

also most evident in tissues with

highest uptake (McEwen and Pfaff, 1970).

The inhibition of

H-estradiol uptake by a prior injection of CI-628 corroborates the finding of Chazal et al. (1975).

In the present

study inhibition of the low levels of uptake in the cerebral

cortex was also found.

This finding is consistent with

the previously demonstrated reduction of cortical nuclear
3

H-estradiol binding by a prior injection of unlabelled

estradiol (Zigmond and McEwen, 1970; Roy and Wade, unpublished)
as well as autoradiographic evidence thatsome ^H-estradiol

binding occurs in this "non- target" tissue (Pfaff and
Keiner, 1973).

Nafoxidine and MER-25 are also capable of inhibiting
the uptake of

optic area.

3

H-estradiol into the hypothalamus and pre-

Nafoxidine is less effective than CI-628, but

this may reflect the difference in injection vehicle

(sesame oil vs. saline) rather than a substantial difference
in affinity for neural estrogen receptors.

MER-25 to inhibit 2-hour uptake when given
3

The failure of
2

hours before

H-estradiol is probably due to solubility characteristics

83

of MER-25.

MER-25 is not soluble in physiological
saline,
whereas CI-628 and nafoxidine are. However, when
MER-25
ikO mg)

is given adequate time to reach the brain
(12 hours),

it inhibits 2-hour uptake of

%-estradiol

as nafoxidine

1

(i;

mg)

(Figure

cf.

Figure

in the inhibition of brain uptake of
is

the same degree

to
,

This delay

3

H-estradiol by MER-25

relevant to the interpretation of experiments intended

to establish the time-course of the effects of estradiol by

using this antiestrogen (Shirley, Wolinsky, and Schwartz,
1968).

The finding that an injection of CI-628 2 hours after
an injection of -^H-estradiol reduces the content of radio-

activity in the hypothalamus- POA 10 hours later is at
variance with an earlier report by Whalen and Gorzalka
(1973).

These authors demonstrated that CI-628 subsequent

to an intravenous estradiol injection is capable of inhibiting

female sexual behavior, but they did not find significant

inhibition of hypothalamic

H-estradiol uptake.

We find

a SS% reduction of whole homogenate radioactivity and a

83^ reduction of nuclear radioactivity in the hypothalamusPOA,

This discrepancy is probably due to differences in

dosage:

Whalen and Gorzalka used a lower dose of CI-628

for their uptake study (100 ug) than for their behavioral

study (1 mg.).

This was rationalized on the grounds that

the estradiol dose was also lowered, from

1;

ug to .3 ug.

However, an intravenous dose of .3 ug of estradiol or a

subcutaneous injection of .5 ug of estradiol more than half-

saturates nuclear binding in the hypothalainus
(Anderson,
Peck, and Clark, 1973; Roy and Wade, unpublished),
so lower-

ing the estradiol dose from

I|.

ug to .3 ug probably does

not lower the es tradiol-receptor complex concentration by
10-fold.
studies,

We used the same dose for behavioral and uptake
i|

mg, which was higher than the doses used by

Whalen and Borzalka,
The greater inhibition of 12 hour retention than 2 hour

uptake by both MER-25 and nafoxidine probably also reflects

displacement of estradiol by the antiestrogens .

Therefore,

it is likely that the brain cells which concentrate estradiol

do not differ in this respect from cells of the anterior

pituitary and uterus in which antiestrogens are capable of
displacing bound estradiol (Callantine, Clemens, and Shih,
1968; Whalen and Gorzalka, 1973).

It is also likely that

unlabelled estradiol would be capable of displacing bound
3

H-estradiol in the brain as it does in the uterus (DeHertogh,

Ekka, Vanderheyden, and Hoet, 1971).

The functional significance of the low levels of bound
•^H-estradiol at long time intervals after injection has not

been clearly established or discounted.

The RNA synthesis

inhibitor, actinomycin D, has been used to suggest a role
of genetic transcription in estradiol induction of sexual

behavior and positive feedback on LH release, and it effectively inhibits these responses when given 12-13 hours after
estradiol (Jackson, 1973; Whalen, Gorzalka, DeBold, Quadagno,
PIo,

and Hough, 197U)

.

CI~628 given up to 6 hours after
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estradiol completely blocks the induction
of lordosis, and
some inhibition of lordosis is produced
by injections as
late as l8 hours after estradiol, or
5 hours before testing
(Whalen and Gorzalka, 1973). Blaustein and
Wade (unpublished)
have recently found that the period of estrous
conditioning
produced by estradiol benzoate (EB) can be shortened
by CI628 administered after the onset of sexual receptivity.

Thus,

while the interval from the initial uptake of estradiol
to
the appearance of its behavioral effects has been
reasonably

well characterized (Green, Luttge, and Whalen,
1970), the

duration of estradiol's effects after it is removed from
brain cell nuclei needs further clarification.

It is

possible that the low levels which are retained in nuclei
for at least

2i|

hours after estradiol injections (McEwen,

Pfaff, Chaptal, and Luine, 1975) are exerting significant

effects for most of that time.
A comparison of the behavioral data with the uptake
studies shows that procedures which inhibit behavior also
inhibit brain uptake of ^H-es tradiol .

Both CI-628 and nafoxi-

dine produce inhibition of sexual receptivity as well as

substantial reduction of brain
2

an

hours prior to estradiol.
3

-^H-es

tradiol when injected

CI-628 injected subsequent to

H-estradiol injection reduces brain

3

H-estradiol reten-

tion, and others have demonstrated that CI-628 can inhibit

sexual behavior when injected subsequent to estradiol

(Whalen and Gorzalka, 1973) or EB (Blaustein and Vade,

unpublished).

MER-25 injected 12 hours prior to estradiol
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inhibits both 2-hour uptake and sexual behavior.

injected

-2

hours prior to estradiol inhibits neither the

early uptake of
behavior.

MER-25

3

H-estradiol nor estradiol-induced sexual

Although the 12-hour retention of ^H-estradiol

was inhibited by MER-25, this delayed inhibitory action

was apparently not sufficient to antagonize the higher dose
of estradiol used in the behavioral studies (3 ug cf.

.3 ug).

The behavioral actions of the antiestrogens are

probably due to specific interactions with estrogen-sensitive
tissues rather than toxic effects of the drugs.

The dose

of MER-25 used in this study fails to produce a learned

aversion (Experiment 5), an objective index of toxicity.
The demonstration that antiestrogens are capable of

competing with estradiol for brain estradiol receptors

is

only a first step in determining the mechanism by which they
exert their inhibition of estradiol-induced sexual behavior.
The reasons that this presumed antiestrogen-receptor complex
is less effective than the estradiol-receptor complex

remain to be determined.

One hypothesis (Capony, and Roche-

fort, 1975; Clark and Peck, 1976) of the inhibitory action

of antiestrogens in the uterus suggests that antiestrogens

are capable of binding to cytosol receptors and are fully

capable of translocating them to the nucleus in order to

produce an initial estrogenic response.

However, the

antiestrogen-receptor complex fails to cause the replenishment of the cytosol receptors which

is

required for a full

»
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estrogenic response, or causes only a delayed
replenishment. A delay of replenishment has also been
suggested as
a mechanism of antagonism for behavioral responses
(Whalen,

Martin, and Olsen, 1975).

This hypothesis as well as others

(Katzenellenbogen, and Ferguson, 1975; Ruh and Ruh,

19714.)

presupposes competition of the antiestrogen and estrogen
for the estrogen receptors.

Beyond this competition,

demonstrated here and elsewhere, there is at present little
evidence to support any particular hypothesis of antiestrogens' actions in the central nervous system.

Some experiments which have provided evidence that a

failure of replenishment is a mechanism of antagonism in
the uterus have not produced analogous results when trans-

ferred to behavioral paradigms.

For example, when an

(antiestrogen and estrogen are given concurrently, no inhi-

bition of the estrogen's effect on uterine weight
at

21^

hoursj (Clark,

is

seen

Peck, and Anderson, 1971;; Lerner,

Holthaus, and Thompson, 1958)

»

but in a similar paradigm

asxual behavior can be totally inhibited.

Also CI-628 and

nafoxidine by themselves produce an initial estrogenic
response on uterine weight and morphology (Clark, Peck,

and Anderson,

19714-;

Kang, Anderson, and DeSombre, 1975)

whereas there is no evidence of an estrogenic effect of
these ajities trogens for normal female sexual behavior in
rats (Aral and Gorski, I968; Meyerson and Lindstrom, 1968;

Powers, 1975; Ross, Shryne, Gorski, and Marshall, 1973;

Sodersten,

I97I4.).

It should be noted that some estrogenic
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central responses to antiestrogens have been
reported:

MER-25 and CI-628 have estrogenic central effects
on the
regulation of eating behavior (PART I); MER-25 acts
as

an

estrogen on male copulatory behavior

(

Baum and Vreeburg,

1976); CI-628 produces estrogenic responses on certain

hypothalamic enzyme activities (Luine, Wallach, and McEwen,
1975); and cJLs-clomiphene can facilitate or inhibit

sexual behavior in female guinea pigs depending on the

experimental paradigm (Walker and Peder, in preparation).
Therefore, the subcellular actions of antiestrogens that
allox>r

them to inhibit estradiol-induced female sexual

behavior are likely to be partially estrogenic actions.

Characterization of the partial actions of the antiestrogens may suggest which aspects of natural estrogen action
are important in the induction of sexual behavior, as well
as

which aspects are important in the effects of estrogens

on eating.

The results presented here are not inconsistent

with a receptor-mediated nuclear action of estradiol to
Induce sexual receptivity, but actual support for this

notion will require assays of receptor dynamics and other
responses with and without antiestrogen involvement,

Antiestrogens may thus be useful in two ways:

First,

for sexual behavior and other responses which antiestrogens

inhibit, an analysis of subcellular responses which anti-

estrogens prevent may tentatively link the estrogenic

induction of a behavior to certain" subcellular responses.

89

For example, if anties trogens prevented the nuclear
localization of receptors, it would suggest, though not

establish,

that nuclear localization of the receptors which antiestrogens do elicit might be involved in the behavioral effects
that antiestrogens induce.

Thus the antiestrogens are

actually partial estrogens and partial antiestrogens,

depending on the behavior observed, and these estrogenic
and estrogen-antagonizing behavioral effects may be corre-

lated with subcellular responses.
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